Noetic invests globally to build emerging technologies in molecular therapeutics/biotech, digital health, medical devices, and wellness with a focus on mental health, pain, and other complications resulting from the central nervous system
Location: Canada, Ontario, Toronto
Employees: 1-10
Founded date: 2020
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A
Portfolio 27
| Date | Name | Website | Total Raised | Location |
| 15.10.2024 | Alexander ... | shulginresearch.net | - | - |
| 29.11.2022 | Apollo Neu... | apolloneuro.com | $15M | United Sta... |
| - | Bexson Bio... | bexsonbiomedical.com | $4.8M | United Sta... |
| - | Terran Bio... | terranbiosciences.com | - | - |
| - | Delix Ther... | delixtherapeutics.com | $100M | United Sta... |
| - | Vivian Ros... | frequencymind.com | - | United Sta... |
| - | Psygen | psygen.ca | - | Canada, Al... |
| - | Eleusis | eleusisltd.com | - | United Kin... |
| - | Wake Netwo... | wake.net | $3.5M | Canada, On... |
| - | Rythmia Li... | rythmialifeadvancement.com | - | - |
Show more
Mentions in press and media 3
| Date | Title | Description |
| 12.05.2023 | 11 investors predict a colorful, if difficult, future for psychedelic startups | How far has the psychedelics medicines industry come over the past 12 months? Well, it depends on where you look. If you look at the stock market, the view isn’t very good: the charts are all down and in the red, and all you can see are psy... |
| 16.03.2023 | Meet the top 14 VCs who've bet the most cash on turning psychedelics into medical treatments | Sean McLintock, Sonia Weiss Pick, Michael Sobeck, and Nikolay Tretiyakov Neo Kuma Ventures, WPSS.bio, Ambria Capital, Leafly Tunnel, Tyler Le/Insider This story is available exclusively to Insider subscribers. Become an Insider and start re... |
| 04.05.2022 | Psychedelics startups are on a long journey to consumer markets, but these 5 VCs are taking the ride | “Like a pressure cooker, COVID blew the lid off what was a simmering mental health crisis for over a decade,” VC Tim Schlidt told TechCrunch. According to the World Health Organization, the global prevalence of anxiety and depression increa... |